Pharmacology, Toxicology and Pharmaceutical Science
Rectum Cancer
100%
Recurrent Disease
66%
Chemotherapy
66%
Overall Survival
66%
Distant Metastasis
66%
Recurrence Free Survival
66%
Rectum Carcinoma
66%
Lymph Node Metastasis
33%
Chemoradiation Therapy
33%
Colon Carcinoma
33%
Mortality Rate
33%
Recurrence Risk
33%
Postoperative Complication
33%
Keyphrases
Clinical Outcomes
100%
Colorectal Cancer
100%
Local Treatment
100%
Radical Resection
100%
Overall Survival
16%
Distant Metastasis
16%
Recurrence-free Survival
16%
Locoregional Recurrence
16%
Adjuvant Chemotherapy
16%
Low Anterior Resection
16%
Rectal Adenocarcinoma
16%
Mortality Rate
8%
Colon Cancer
8%
Recurrence Rate
8%
Neoadjuvant Chemoradiotherapy (nCRT)
8%
Local Radiotherapy
8%
Nodal Metastasis
8%
Perioperative Complication Rate
8%
Surgical Morbidity
8%
Lymph Node Metastasis Rate
8%
Abdominoperineal Resection
8%
Transanal Excision
8%
Hypointense Lesions
8%
Reversal Rate
8%
Medicine and Dentistry
Local Therapy
100%
Rectum Cancer
100%
Radical Resection
100%
Recurrent Disease
16%
Overall Survival
16%
Distant Metastasis
16%
Recurrence Free Survival
16%
Rectum Carcinoma
16%
Lower Anterior Resection
16%
Adjuvant Chemotherapy
16%
Mortality Rate
8%
Surgery
8%
Lymph Node Metastasis
8%
Postoperative Complication
8%
Radiation Therapy
8%
Chemoradiotherapy
8%
Recurrence Risk
8%
Colon Carcinoma
8%
Nodal Metastasis
8%